Last updated: 16 July 2019 at 5:11am EST

Laurence L Betterley Net Worth




The estimated Net Worth of Laurence L Betterley is at least $9.57 Million dollars as of 15 August 2017. Laurence Betterley owns over 4,443 units of Cardiovascular Systems stock worth over $4,434,980 and over the last 16 years Laurence sold CSII stock worth over $5,134,733.

Laurence Betterley CSII stock SEC Form 4 insiders trading

Laurence has made over 30 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently Laurence sold 4,443 units of CSII stock worth $136,578 on 15 August 2017.

The largest trade Laurence's ever made was selling 20,764 units of Cardiovascular Systems stock on 17 November 2016 worth over $560,836. On average, Laurence trades about 4,434 units every 51 days since 2009. As of 15 August 2017 Laurence still owns at least 221,749 units of Cardiovascular Systems stock.

You can see the complete history of Laurence Betterley stock trades at the bottom of the page.



What's Laurence Betterley's mailing address?

Laurence's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.



What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.



Complete history of Laurence Betterley stock trades at Cardiovascular Systems

Insider
Trans.
Transaction
Total value
Laurence L Betterley
Chief Financial Officer
Sale $136,578
15 Aug 2017
Laurence L Betterley
Chief Financial Officer
Sale $227,475
27 Feb 2017
Laurence L Betterley
Chief Financial Officer
Sale $560,836
17 Nov 2016
Laurence L Betterley
Chief Financial Officer
Sale $85,489
22 Aug 2016
Laurence L Betterley
Chief Financial Officer
Sale $229,944
1 Sep 2015
Laurence L Betterley
Chief Financial Officer
Sale $203,424
17 Aug 2015
Laurence L Betterley
Chief Financial Officer
Sale $380,000
26 Feb 2015
Laurence L Betterley
Chief Financial Officer
Sale $370,149
11 Feb 2015
Laurence L Betterley
Chief Financial Officer
Sale $381,581
30 Jan 2015
Laurence L Betterley
Chief Financial Officer
Sale $134,705
3 Sep 2014
Laurence L Betterley
Chief Financial Officer
Sale $190,894
21 Aug 2014
Laurence L Betterley
Chief Financial Officer
Sale $167,628
18 Aug 2014
Laurence L Betterley
Chief Financial Officer
Sale $114,859
16 Jul 2014
Laurence L Betterley
Chief Financial Officer
Sale $512,473
30 Jun 2014
Laurence L Betterley
Chief Financial Officer
Sale $351,100
27 Feb 2014
Laurence L Betterley
Chief Financial Officer
Sale $36,308
22 Nov 2013
Laurence L Betterley
Chief Financial Officer
Sale $54,742
19 Sep 2013
Laurence L Betterley
Chief Financial Officer
Sale $90,501
17 Sep 2013
Laurence L Betterley
Chief Financial Officer
Sale $179,403
28 Aug 2013
Laurence L Betterley
Chief Financial Officer
Sale $231,391
23 Aug 2013
Laurence L Betterley
Chief Financial Officer
Sale $32,160
15 Aug 2013
Laurence L Betterley
Chief Financial Officer
Sale $129,738
30 Jul 2013
Laurence L Betterley
Chief Financial Officer
Sale $3,756
24 Aug 2012
Laurence L Betterley
Chief Financial Officer
Sale $43,264
21 Aug 2012
Laurence L Betterley
Chief Financial Officer
Sale $50,309
16 Aug 2012
Laurence L Betterley
Chief Financial Officer
Sale $13,442
13 Aug 2012
Laurence L Betterley
Chief Financial Officer
Sale $29,968
18 Jul 2012
Laurence L Betterley
Chief Financial Officer
Sale $96,391
16 Aug 2011
Laurence L Betterley
Chief Financial Officer
Sale $38,217
19 Jul 2011
Laurence L Betterley
Chief Financial Officer
Sale $58,007
15 Apr 2011


Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include: